Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Drug studies in newborns: a therapeutic imperative.

Giacoia GP, Taylor-Zapata P, Zajicek A.

Clin Perinatol. 2012 Mar;39(1):11-23. doi: 10.1016/j.clp.2011.12.016. Epub 2012 Jan 21. Review.

PMID:
22341533
2.

A quality improvement approach to optimizing medication use in the neonatal intensive care unit.

Ellsbury DL, Ursprung R.

Clin Perinatol. 2012 Mar;39(1):1-10. doi: 10.1016/j.clp.2011.12.001. Epub 2012 Jan 11. Review.

PMID:
22341532
3.

Criteria supporting the study of drugs in the newborn.

Ward RM, Benitz WE, Benjamin DK Jr, Blackmon L, Giacoia GP, Hudak M, Lasky T, Rodriguez W, Selen A.

Clin Ther. 2006 Sep;28(9):1385-98. Review.

PMID:
17062311
4.

Therapeutic drug monitoring--the appropriate use of drug level measurement in the care of the neonate.

Young TE.

Clin Perinatol. 2012 Mar;39(1):25-31. doi: 10.1016/j.clp.2011.12.009. Epub 2012 Jan 11. Review.

PMID:
22341534
5.
6.

Cardiovascular support in preterm infants.

Evans JR, Lou Short B, Van Meurs K, Cheryl Sachs H.

Clin Ther. 2006 Sep;28(9):1366-84. Review.

PMID:
17062310
7.

Pharmacological research in neonatology.

Dotta A, Braguglia A, Salvatori G.

J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 1:44-6. doi: 10.3109/14767058.2011.607580. Review.

PMID:
21942589
8.

Medication errors in the neonate.

Sorrentino E, Alegiani C.

J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 4:91-3. doi: 10.3109/14767058.2012.714994. Review.

PMID:
22958031
9.

Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities.

Jacqz-Aigrain E.

Early Hum Dev. 2011 Mar;87 Suppl 1:S27-30. doi: 10.1016/j.earlhumdev.2011.01.007. Epub 2011 Jan 26. Review.

PMID:
21269785
10.

Off-label therapies for newborns. Miracles or mistakes?

Askin DF.

AWHONN Lifelines. 2006 Apr-May;10(2):160-2. Review. No abstract available.

PMID:
16712579
11.

Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative.

Baer GR, Nelson RM; Ethics Group of the Newborn Drug Development Initiative.

Clin Ther. 2006 Sep;28(9):1399-407. Review.

PMID:
17062312
12.

The Vermont Oxford Network: evidence-based quality improvement for neonatology.

Horbar JD.

Pediatrics. 1999 Jan;103(1 Suppl E):350-9. Review.

PMID:
9917477
13.

Selected Proceedings of the NICHD/FDA newborn drug development initiative: Part II.

Giacoia GP, Mattison DR.

Clin Ther. 2006 Sep;28(9):1337-41. Review.

PMID:
17062307
14.

Adverse drug reactions in neonates.

Knight M.

J Clin Pharmacol. 1994 Feb;34(2):128-35. Review.

PMID:
8163712
15.

Care of very premature infants: looking to the future.

Rozé JC, Bréart G.

Eur J Obstet Gynecol Reprod Biol. 2004 Nov 15;117 Suppl 1:S29-32. Review.

PMID:
15530713
16.

Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.

Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H.

J Clin Pharm Ther. 2009 Jun;34(3):277-87. Review.

PMID:
19650250
17.

Functional echocardiography: an emerging clinical tool for the neonatologist.

Kluckow M, Seri I, Evans N.

J Pediatr. 2007 Feb;150(2):125-30. Review. No abstract available.

PMID:
17236886
18.

Developmental care for high-risk newborns: emerging science, clinical application, and continuity from newborn intensive care unit to community.

Browne JV.

Clin Perinatol. 2011 Dec;38(4):719-29. doi: 10.1016/j.clp.2011.08.003. Epub 2011 Oct 24. Review.

PMID:
22107900
19.

Neonatal and infant care and outcomes.

Little GA.

Curr Opin Obstet Gynecol. 1992 Feb;4(1):55-60. Review.

PMID:
1543831
20.

[Off-label drugs use in children--clinical perspective].

Kwinta P.

Przegl Lek. 2011;68(1):1-3. Review. Polish.

PMID:
21563434
Items per page

Supplemental Content

Write to the Help Desk